On June 18, 2026, Gil Issachar transitioned from Chief Technology Officer to Head of AI and Neuroscience under a new employment agreement with Deel Innovation Ltd. Consequently, the board of directors determined that Issachar is no longer classified as a Section 16 or executive officer of the company. Firefly Neuroscience operates in the healthcare technology industry, providing AI-driven neuroscience solutions.
